Site icon Market Globalist

Will these updates push Curaleaf Holdings, Inc. (CSE: CURA) higher?

Best Drone Stocks

Best Drone Stocks

Recent highlights

Curaleaf Holdings, Inc. (CSE: CURA) is a leading U.S. provider of consumer products in ‎cannabis. It opened trading at the price of $14.50 Over the counter and closed 8.28% higher ‎than the previous close at $14.35. The stock has a market capitalization of 7,540,641,962. Its ‎volume during the last trading session was 2,878,287 in contrast with the 30-days volume of ‎‎1,094,592.‎

Discover Tomorrow's Stocks Today!

When it comes to discovering hidden gems within the stock market, Stock Wire News has consistently provided invaluable insights. Stock Wire News invites you to explore their upcoming Wealth Building Report. This report will shine a spotlight on little-known companies with the potential for substantial growth in 2024, and it's completely FREE for a limited time.

Claim the free report now by clicking here and start discovering the hidden gems of the market
Sponsored

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Key developments

On January 6, 2021, CURAannounced that it is commencing an overnight marketed offering ‎of subordinate voting shares of the Company.‎

Read More

Under the prospectus supplement to the Company’s existing base shelf prospectus dated ‎November 2, 2020, the Offered Securities will be offered in all provinces other than Québec.‎

To qualified institutional buyers on a private placement basis in the United States under an ‎exemption from the registration requirements of the United States Securities Act of 1933, as ‎amended. It is expected that the prospectus supplement will be filed on January 8, 2020.‎

Market conditions will determine the Offering’s final terms, which will be determined when ‎pricing is determined. No assurance can be given as to whether or when the Offering will be ‎completed or as to its actual size or terms. The Canadian Securities Exchange will be ‎required to approve the Offering, in addition to the market and other conditions.‎
the company also intends to grant the underwriters the right to purchase an additional 15% ‎of the Offered Securities under the proposed Offering.‎

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

The Offering’s net proceeds are intended to be used for general corporate purposes and to ‎finance working capital. Canaccord Genuity is the sole underwriter of the Offering.‎

Furthermore, it is reported that the results of Georgia’s key Senate runoffs on Tuesday are ‎expected to have significant ramifications on cannabis reform on a federal level.‎